CJCV2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CJCV2, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of CJCV2 With and Without ALFQ [Phase 1]